Skip to content

Clinical trials

Lung Diseases, Obstructive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20132
20146
20154
20163
20171
20182
20192
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Novartis Pharmaceuticals2
RWTH Aachen University2
Universitätsklinikum Hamburg-Eppendorf2
Grifols Therapeutics LLC1
Heidelberg University1
Morair Medtech, LLC1
Novartis1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive25
Lung Diseases18
Respiratory Tract Diseases16
Asthma14
Bronchial Diseases11
Pulmonary Disease, Chronic Obstructive9
Hypersensitivity3
Immune System Diseases3
Emphysema2
Hypersensitivity, Immediate2

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.